|34.51||+0.7700||+2.28%||Vol 42.50M||1Y Perf -21.74%|
|Jul 2nd, 2020 16:03 DELAYED|
|1.35 4.00%||- -%|
|Target Price||40.78||Analyst Rating||Moderate Buy 2.00|
|Potential %||18.17||Finscreener Ranking||★★★+ 51.94|
|Insiders Trans % 3/6/12 mo.||-100/-87/-89||Value Ranking||★★★★ 59.17|
|Insiders Value % 3/6/12 mo.||-100/-99/-98||Growth Ranking||★★★+ 55.50|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-99/-98||Income Ranking||★★★+ 51.90|
|Market Cap||191.70B||Earnings Rating||Sell|
|Price Range Ratio 52W %||39.75||Earnings Date||28th Jul 2020|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||28th Jul 2020|
|Estimated EPS Next Report||0.64|
|EPS Growth Next 5 Years %||4.40|
|Avg. Weekly Volume||38.68M|
|Avg. Monthly Volume||35.00M|
|Avg. Quarterly Volume||28.28M|
Pfizer Inc. (NYSE: PFE) stock closed at 34.51 per share at the end of the most recent trading day (a 2.28% change compared to the prior day closing price) with a volume of 42.93M shares and market capitalization of 191.70B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 92400 people. Pfizer Inc. CEO is Albert Bourla.
The one-year performance of Pfizer Inc. stock is -21.74%, while year-to-date (YTD) performance is -11.92%. PFE stock has a five-year performance of 5.07%. Its 52-week range is between 27.88 and 44.56, which gives PFE stock a 52-week price range ratio of 39.75%
Pfizer Inc. currently has a PE ratio of 11.40, a price-to-book (PB) ratio of 2.74, a price-to-sale (PS) ratio of 3.58, a price to cashflow ratio of 12.90, a PEG ratio of 2.32, a ROA of 9.81%, a ROC of 15.44% and a ROE of 25.51%. The company’s profit margin is 31.23%, its EBITDA margin is 48.40%, and its revenue ttm is $50.66 Billion , which makes it $9.12 revenue per share.
Of the last four earnings reports from Pfizer Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.64 for the next earnings report. Pfizer Inc.’s next earnings report date is 28th Jul 2020.
The consensus rating of Wall Street analysts for Pfizer Inc. is Moderate Buy (2), with a target price of $40.78, which is +18.17% compared to the current price. The earnings rating for Pfizer Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Pfizer Inc. has a dividend yield of 4.66% with a dividend per share of $1.52 and a payout ratio of 50.00%.
Pfizer Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 29.59, ATR14 : 0.91, CCI20 : 41.88, Chaikin Money Flow : -0.16, MACD : -0.77, Money Flow Index : 61.09, ROC : 2.83, RSI : 52.26, STOCH (14,3) : 89.78, STOCH RSI : 1.00, UO : 59.48, Williams %R : -10.22), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Pfizer Inc. in the last 12-months were: Albert Bourla (Option Excercise at a value of $1 813 810), Alexander R. Mackenzie (Option Excercise at a value of $1 038 253), Angela Hwang (Option Excercise at a value of $501 313), Dawn Rogers (Option Excercise at a value of $1 010 048), Dawn Rogers (Sold 13 000 shares of value $495 690 ), Douglas M. Lankler (Option Excercise at a value of $1 063 269), Douglas M. Lankler (Sold 65 000 shares of value $2 460 372 ), Frank A. D'Amelio (Option Excercise at a value of $9 766 544), Jennifer B. Damico (Sold 4 362 shares of value $162 441 ), John Young (Option Excercise at a value of $7 765 057), Loretta V. Cangialosi (Option Excercise at a value of $1 586 062), Michael Goettler (Option Excercise at a value of $625 459), Mikael Dolsten (Sold 95 353 shares of value $3 602 681 ), Rady A. Johnson (Option Excercise at a value of $437 811), Rady A. Johnson (Sold 13 125 shares of value $503 475 ), Sally Susman (Option Excercise at a value of $5 008 366), Scott Gottlieb (Buy at a value of $141 157)
Copyright (c) 2020. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.com, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.